Dermata Therapeutics Inc(DRMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DRMA Dermata Therapeutics Inc

Post-Mkt 11-02 19:19:10 EST

0.7538

-0.0212

-2.74%

盘后0.7784

+0.0246+3.26%

18:57 EST

High0.8193	Low0.7440	Vol140.37K
Open0.7708	D1 Closing0.7750	Amplitude9.72%
Mkt Cap3.74M	Tradable Cap2.89M	Total Shares4.96M
T/O108.25K	T/O Rate3.66%	Tradable Shares3.83M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DRMA","market":"US","secType":"STK","nameCN":"Dermata Therapeutics Inc","latestPrice":0.7538,"timestamp":1793653200000,"preClose":0.775,"halted":0,"volume":140372,"hourTrading":{"tag":"盘后","latestPrice":0.7784,"preClose":0.7538,"latestTime":"18:57 EST","volume":20947,"amount":16040.00898538,"timestamp":1793663829068,"change":0.0246,"changeRate":0.032635,"amplitude":0.032635},"delay":0,"changeRate":-0.027354838709677413,"floatShares":3830899,"shares":4955207,"eps":-4.3864,"marketStatus":"Post-Mkt","change":-0.0212,"latestTime":"11-02 19:19:10 EST","open":0.7708,"high":0.8193,"low":0.744,"amount":108248.6679204,"amplitude":0.097161,"askPrice":0.8523,"askSize":100,"bidPrice":0.7495,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-4.3864,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793667600000},"marketStatusCode":4,"adr":0,"listingDate":1628827200000,"exchange":"NASDAQ","adjPreClose":0.775,"preHourTrading":{"tag":"盘前","latestPrice":0.7701,"preClose":0.775,"latestTime":"09:29 EST","volume":691,"amount":531.1848013599999,"timestamp":1793629752648,"change":-0.0049,"changeRate":-0.006323,"amplitude":0.020387},"postHourTrading":{"tag":"盘后","latestPrice":0.7784,"preClose":0.7538,"latestTime":"18:57 EST","volume":20947,"amount":16040.00898538,"timestamp":1793663829068,"change":0.0246,"changeRate":0.032635,"amplitude":0.032635},"volumeRatio":1.237061},"requestUrl":"/m/hq/s/DRMA","defaultTab":"news","newsList":[{"id":"2679623742","title":"Dermata Therapeutics Advances Tome Clearing Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2679623742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679623742?lang=en_us&edition=fundamental","pubTime":"2026-10-30 05:48","pubTimestamp":1793310497,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics ( ($DRMA) ) has issued an update. On October 29, 2027, Dermata Therapeutics announced that it had enrolled the first participa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-advances-tome-clearing-acne-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-advances-tome-clearing-acne-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DRMA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679232941","title":"Dermata Therapeutics - Expects to Launch Tome Clearing Treatment in First Half of 2027 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2679232941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679232941?lang=en_us&edition=fundamental","pubTime":"2026-10-30 05:29","pubTimestamp":1793309374,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F35D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRMA","BK4007","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679325882","title":"Dermata initiates acne clinical trial of second Tome skincare product","url":"https://stock-news.laohu8.com/highlight/detail?id=2679325882","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679325882?lang=en_us&edition=fundamental","pubTime":"2026-10-30 05:10","pubTimestamp":1793308239,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics (DRMA) announced enrollment of the first participant in a clinical trial evaluating Tome Clearing Treatment, the company’s onc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dermata-initiates-acne-clinical-trial-of-second-tome-skincare-product-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dermata-initiates-acne-clinical-trial-of-second-tome-skincare-product-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","HYLG","DRMA","GDOC","IDNA","BK4007","NVIB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679231687","title":"Dermata Enrolls First Participant in Tome Clearing Treatment Acne Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2679231687","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679231687?lang=en_us&edition=fundamental","pubTime":"2026-10-30 04:40","pubTimestamp":1793306424,"startTime":"0","endTime":"0","summary":"Dermata Enrolls First Participant in Tome Clearing Treatment Acne TrialDermata Therapeutics enrolled the first participant in a clinical trial of Tome Clearing Treatment, its once-weekly acne treatmen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL20VJYg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675531243","title":"US Stocks on the MOVE-Caterpillar, Kimberly-Clark, Bending Spoons","url":"https://stock-news.laohu8.com/highlight/detail?id=2675531243","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675531243?lang=en_us&edition=fundamental","pubTime":"2026-10-16 01:31","pubTimestamp":1792085499,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending SpoonsWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nL4N4611UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","DFH","RPGL","BSP","GEV","CMC","NEM","P","BNY","INTU","TGL","CIGL","FMC","EFX","NVDA","OPK","CABO","CSGP","MU","VNDA","SDST","LH","RKLB","WMT","KMX","HAIN","HL","MAN","INTC","COHR","PAG","VG","EVEX","HPE","DELL","IP","PAYX","DRMA","BBCI","KMB","SMCI","BKR","YRD","TRAX","FHN","SIVR","DRIV","SIG","LDI","PNC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675533985","title":"NASDAQ Trade Halt Volatility Trading Pause at 10:26 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2675533985","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675533985?lang=en_us&edition=fundamental","pubTime":"2026-10-15 22:26","pubTimestamp":1792074409,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 10:26 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nAQN2MOAFF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","DRMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675582883","title":"Dermata announces results from study evaluating Tome Foundational Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2675582883","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675582883?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:20","pubTimestamp":1792066828,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics (DRMA) announced positive topline results from its recently completed cosmetic clinical study evaluating Tome Foundational Tre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dermata-announces-results-from-study-evaluating-tome-foundational-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dermata-announces-results-from-study-evaluating-tome-foundational-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRMA","BK4007","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675584118","title":"Dermata Therapeutics Reports Improved Skin Appearance in Tome Treatment Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2675584118","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675584118?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:12","pubTimestamp":1792066321,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics Reports Improved Skin Appearance in Tome Treatment StudyDermata Therapeutics today announced positive topline results from a completed cosmetic clinical study of its recently laun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL2f5vFF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4539","DRMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661137298","title":"Dermata Therapeutics announces Tome Foundational Treatment open to preorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2661137298","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661137298?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:35","pubTimestamp":1787315721,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics (DRMA) announced that Tome Foundational Treatment, the Company’s first direct-to-consumer skincare product, is now open to pre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dermata-therapeutics-announces-tome-foundational-treatment-open-to-preorders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dermata-therapeutics-announces-tome-foundational-treatment-open-to-preorders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DRMA","STYL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660148000","title":"Dermata Therapeutics Announces Private Placement to Fund DTC Pivot","url":"https://stock-news.laohu8.com/highlight/detail?id=2660148000","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660148000?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971686,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics ( ($DRMA) ) just unveiled an update. On August 16, 2026, Dermata Therapeutics entered into definitive securities purchase agre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-announces-private-placement-to-fund-dtc-pivot?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-announces-private-placement-to-fund-dtc-pivot?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DRMA","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487799","title":"Dermata Therapeutics Prices USD 3.4 Million Private Placement at USD 1.46 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487799?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969849,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics prices USD 3.4 million private placement at USD 1.46 per shareDermata Therapeutics priced a private placement at-the-market under Nasdaq rules, issuing 2,293,608 common shares or ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL8q9Vc9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","DRMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149415","title":"Maxim Group Sticks to Its Buy Rating for Dermata Therapeutics (DRMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149415?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:17","pubTimestamp":1786709820,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Anthony Vendetti maintained a Buy rating on Dermata Therapeutics yesterday and set a price target of $4.00. The company’s share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-dermata-therapeutics-drma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-dermata-therapeutics-drma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945736","title":"Dermata Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945736","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945736?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:02","pubTimestamp":1786482120,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryDermata Therapeutics IncDRMA.OQreported a quarterly adjusted loss of 74 cents per share for the quarter ended J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44826R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4007","DRMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658458419","title":"Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658458419","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658458419?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:37","pubTimestamp":1786480649,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/DRMA","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658482609","title":"Dermata Net Loss Widens to USD 2,97 Juta in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2658482609","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658482609?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:08","pubTimestamp":1786478910,"startTime":"0","endTime":"0","summary":"Dermata net loss widens to USD 2,97 juta in Q2 FY26Dermata Therapeutics membukukan rugi bersih USD 2,97 juta pada kuartal II, melebar dari USD 1,7 juta setahun sebelumnya.Rugi per saham menyempit ke U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL8qY5vR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DRMA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658254948","title":"Dermata Therapeutics - to Launch First Commercial Product Tome Foundational Treatment on August 25, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658254948","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658254948?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:08","pubTimestamp":1786478901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4481KC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DRMA","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626990","title":"Dermata Therapeutics Inc Expected to Post a Loss of 55 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626990","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626990?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:25","pubTimestamp":1786134306,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics Inc <DRMA.OQ> expected to post a loss of55cents a share - Earnings PreviewDermata Therapeutics IncDRMA.OQDRMA.Ois expected to  show no change in quarterly revenue when it reports  results on August 11  for the period ending June 30 2026LSEG's mean analyst estimate for Dermata Therapeutics Inc is for a loss of 55 cents per share.The one available analyst rating on the shares is \"buy\".The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Dermata Therapeutics Inc is $4.00, about 260.4% above its last closing price of $1.11This summary was machine generated August 7 at 20:25 GMT.  All figures in US dollars unless otherwise stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644608737","title":"Dermata Therapeutics director Kathleen D. Scott disposes of 11 common shares worth $13.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2644608737","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644608737?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:16","pubTimestamp":1781640981,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics director Kathleen D. Scott sold 11 shares of common stock on June 16, 2026 at $1.19.She reported 1 share held indirectly through the Scott 2008 Trust dated March 28, 2008.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dermata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4bPdvj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Dermata Therapeutics director Kathleen D. Scott disposes of 11 common shares worth $13.09","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA","BK4007","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638663438","title":"Dermata Therapeutics Shareholders Approve Equity Plan and Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2638663438","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638663438?lang=en_us&edition=fundamental","pubTime":"2026-05-28 06:09","pubTimestamp":1779919742,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics ( ($DRMA) ) just unveiled an update. On May 27, 2026, Dermata Therapeutics held its 2026 Annual Meeting of Stockholders, where...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-shareholders-approve-equity-plan-and-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-shareholders-approve-equity-plan-and-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4215","BK4007","DRMA","EQR","BK4585","BK4539","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638463959","title":"Dermata Therapeutics shareholders approved equity plan share increase to 402,214 at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638463959","media":"Reuters","labels":["executive","shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638463959?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:58","pubTimestamp":1779915497,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics held its annual shareholder meeting on May 27, 2026.Shareholders authorized an amendment to the 2021 Omnibus Equity Incentive Plan, lifting the share pool to 402,214 shares.Investors also backed the planned issuance of common stock underlying certain warrants tied to a December 23, 2025 securities purchase agreement.Approval was also granted to reprice warrants exercisable for up to 120,734 common shares.CBIZ CPAs was ratified as independent auditor for the year ending Dec. 31, 2026; an adjournment proposal was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dermata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLRX6pV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","DRMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dermatarx.com;ir.dermatarx.com","stockEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.2955},{"period":"3month","weight":-0.3376},{"period":"6month","weight":-0.4173},{"period":"1year","weight":-0.7741},{"period":"ytd","weight":-0.6659}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":-0.0091},{"period":"3month","weight":0.0116},{"period":"6month","weight":0.0487},{"period":"1year","weight":0.1116},{"period":"ytd","weight":0.1082}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.070436},{"month":2,"riseRate":0,"avgChangeRate":-0.221628},{"month":3,"riseRate":0.4,"avgChangeRate":-0.164591},{"month":4,"riseRate":0.4,"avgChangeRate":-0.040018},{"month":5,"riseRate":0,"avgChangeRate":-0.135458},{"month":6,"riseRate":0.2,"avgChangeRate":-0.14152},{"month":7,"riseRate":0.2,"avgChangeRate":-0.125233},{"month":8,"riseRate":0.4,"avgChangeRate":-0.006039},{"month":9,"riseRate":0,"avgChangeRate":-0.131458},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.162647},{"month":11,"riseRate":0.2,"avgChangeRate":-0.072999},{"month":12,"riseRate":0.2,"avgChangeRate":-0.194478}],"exchange":"NASDAQ","name":"Dermata Therapeutics Inc","nameEN":"Dermata Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dermata Therapeutics Inc(DRMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Dermata Therapeutics Inc(DRMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Dermata Therapeutics Inc,DRMA,Dermata Therapeutics Inc股票,Dermata Therapeutics Inc股票老虎,Dermata Therapeutics Inc股票老虎国际,Dermata Therapeutics Inc行情,Dermata Therapeutics Inc股票行情,Dermata Therapeutics Inc股价,Dermata Therapeutics Inc股市,Dermata Therapeutics Inc股票价格,Dermata Therapeutics Inc股票交易,Dermata Therapeutics Inc股票购买,Dermata Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dermata Therapeutics Inc(DRMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Dermata Therapeutics Inc(DRMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}